symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
RBSH,0.008,-10.978223,73270,257063,0,0.005-0.02255,0.0012,"Rebus Holdings, Inc.",USD,0001421204,,75619J103,Other OTC,PNK,Biotechnology,https://www.rebus-corp.com,"Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.",Mr. Raul  Silvestre Esq.,Healthcare,US,1,818 597 7552,2629 Townsgate Road,Westlake Village,CA,91361,,0,https://financialmodelingprep.com/image-stock/RBSH.png,2009-11-04,False,False,True,False,False
